Anticoagulant News and Research

RSS
PolyMedix completes second successful clinical study of PMX-60056

PolyMedix completes second successful clinical study of PMX-60056

CHMP grants positive opinion to extend the use of Angiox to patients undergoing PCI

CHMP grants positive opinion to extend the use of Angiox to patients undergoing PCI

Patients who are severely ill with H1N1 are at risk for developing PE, says study

Patients who are severely ill with H1N1 are at risk for developing PE, says study

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Researchers engineer antidotes for blood-thinner aptamers

Researchers engineer antidotes for blood-thinner aptamers

Polymedix commences Phase 1B study of novel anticoagulant reversing agent

Polymedix commences Phase 1B study of novel anticoagulant reversing agent

New anticoagulant therapy has fewer side-effects than warfarin

New anticoagulant therapy has fewer side-effects than warfarin

Heparin-induced skin lesions may indicate platelets deficit

Heparin-induced skin lesions may indicate platelets deficit

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Researchers to present results of HORIZONS-AMI trial at TCT scientific symposium

Researchers to present results of HORIZONS-AMI trial at TCT scientific symposium

Winners of "Passion & Results" Award announced by Instrumentation Laboratory

Winners of "Passion & Results" Award announced by Instrumentation Laboratory

Researchers find new technique for long-term treatment of DVT

Researchers find new technique for long-term treatment of DVT

New patent grant for oligonucleotide modulators of blood coagulation factor aptamers

New patent grant for oligonucleotide modulators of blood coagulation factor aptamers

First patient enrolled in Phase 2b RADAR clinical trial

First patient enrolled in Phase 2b RADAR clinical trial

ThromboGenics shortlisted for two awards at the Scrip Awards 2009

ThromboGenics shortlisted for two awards at the Scrip Awards 2009

Haemonetics acquires SEBRA's blood collection and processing business

Haemonetics acquires SEBRA's blood collection and processing business

Warfarin therapy provides substantial protection for elder patients with atrial fibrillation

Warfarin therapy provides substantial protection for elder patients with atrial fibrillation

FDA approves Hospira's six new vial presentations of heparin

FDA approves Hospira's six new vial presentations of heparin

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.